Final phase II results for sunitinib (SU) in Japanese pts with well-differentiated pancreatic neuroendocrine tumor (NET)

Final phase II results for sunitinib (SU) in Japanese pts with well-differentiated pancreatic neuroendocrine tumor (NET)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2015-11, Vol.26, p.vii74-vii74
Hauptverfasser: Ito, Tetsuhide, Okusaka, Takuji, Tori, Masayuki, Hashigaki, Satoshi, Kimura, Nobuyuki, Ohki, Emiko, Sawaki, Akira, Nishida, Toshirou, Yamao, Kenji, Imamura, Masayuki
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page vii74
container_issue
container_start_page vii74
container_title Annals of oncology
container_volume 26
creator Ito, Tetsuhide
Okusaka, Takuji
Tori, Masayuki
Hashigaki, Satoshi
Kimura, Nobuyuki
Ohki, Emiko
Sawaki, Akira
Nishida, Toshirou
Yamao, Kenji
Imamura, Masayuki
description
doi_str_mv 10.1093/annonc/mdv466.02
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdv466_02</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419468361</els_id><sourcerecordid>S0923753419468361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1342-a52a7d69ccfdb6c3a237d1dd6ccff8f9ef5e74846389fda15ed289f80f5697f3</originalsourceid><addsrcrecordid>eNp1kM1PAjEQxRujiYjePfYIh4V-7Fe9GQKKIXoQz01pp6Fm6ZJ2F_S_t2a9eprJ5Pde5j2E7imZUSL4XHnfej0_mFNeljPCLtCIFqXIapLTSzQigvGsKnh-jW5i_CSElIKJEfpaOa8afNyrCHi9xgFi33QR2zbg2HvXOe92ePL-McXO4xd1VB4SeUzI2XV7fIamyYyzFgL4zqkODE6MDqA6p7GHPrTgTauD84C7_pB8J6_L7fQWXVnVRLj7m2O0XS23i-ds8_a0XjxuMk15zjJVMFWZUmhtza7UXDFeGWpMmQ62tgJsAVVe5yWvhTWKFmBY2mpiU_jK8jEig60ObYwBrDwGd1DhW1Iif4uTQ3FyKE4SliQPgwTSWycHQUbtwGswLoDupGnd_-If_VR69g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Final phase II results for sunitinib (SU) in Japanese pts with well-differentiated pancreatic neuroendocrine tumor (NET)</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ito, Tetsuhide ; Okusaka, Takuji ; Tori, Masayuki ; Hashigaki, Satoshi ; Kimura, Nobuyuki ; Ohki, Emiko ; Sawaki, Akira ; Nishida, Toshirou ; Yamao, Kenji ; Imamura, Masayuki</creator><creatorcontrib>Ito, Tetsuhide ; Okusaka, Takuji ; Tori, Masayuki ; Hashigaki, Satoshi ; Kimura, Nobuyuki ; Ohki, Emiko ; Sawaki, Akira ; Nishida, Toshirou ; Yamao, Kenji ; Imamura, Masayuki</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdv466.02</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2015-11, Vol.26, p.vii74-vii74</ispartof><rights>2015 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Ito, Tetsuhide</creatorcontrib><creatorcontrib>Okusaka, Takuji</creatorcontrib><creatorcontrib>Tori, Masayuki</creatorcontrib><creatorcontrib>Hashigaki, Satoshi</creatorcontrib><creatorcontrib>Kimura, Nobuyuki</creatorcontrib><creatorcontrib>Ohki, Emiko</creatorcontrib><creatorcontrib>Sawaki, Akira</creatorcontrib><creatorcontrib>Nishida, Toshirou</creatorcontrib><creatorcontrib>Yamao, Kenji</creatorcontrib><creatorcontrib>Imamura, Masayuki</creatorcontrib><title>Final phase II results for sunitinib (SU) in Japanese pts with well-differentiated pancreatic neuroendocrine tumor (NET)</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp1kM1PAjEQxRujiYjePfYIh4V-7Fe9GQKKIXoQz01pp6Fm6ZJ2F_S_t2a9eprJ5Pde5j2E7imZUSL4XHnfej0_mFNeljPCLtCIFqXIapLTSzQigvGsKnh-jW5i_CSElIKJEfpaOa8afNyrCHi9xgFi33QR2zbg2HvXOe92ePL-McXO4xd1VB4SeUzI2XV7fIamyYyzFgL4zqkODE6MDqA6p7GHPrTgTauD84C7_pB8J6_L7fQWXVnVRLj7m2O0XS23i-ds8_a0XjxuMk15zjJVMFWZUmhtza7UXDFeGWpMmQ62tgJsAVVe5yWvhTWKFmBY2mpiU_jK8jEig60ObYwBrDwGd1DhW1Iif4uTQ3FyKE4SliQPgwTSWycHQUbtwGswLoDupGnd_-If_VR69g</recordid><startdate>201511</startdate><enddate>201511</enddate><creator>Ito, Tetsuhide</creator><creator>Okusaka, Takuji</creator><creator>Tori, Masayuki</creator><creator>Hashigaki, Satoshi</creator><creator>Kimura, Nobuyuki</creator><creator>Ohki, Emiko</creator><creator>Sawaki, Akira</creator><creator>Nishida, Toshirou</creator><creator>Yamao, Kenji</creator><creator>Imamura, Masayuki</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201511</creationdate><title>Final phase II results for sunitinib (SU) in Japanese pts with well-differentiated pancreatic neuroendocrine tumor (NET)</title><author>Ito, Tetsuhide ; Okusaka, Takuji ; Tori, Masayuki ; Hashigaki, Satoshi ; Kimura, Nobuyuki ; Ohki, Emiko ; Sawaki, Akira ; Nishida, Toshirou ; Yamao, Kenji ; Imamura, Masayuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1342-a52a7d69ccfdb6c3a237d1dd6ccff8f9ef5e74846389fda15ed289f80f5697f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ito, Tetsuhide</creatorcontrib><creatorcontrib>Okusaka, Takuji</creatorcontrib><creatorcontrib>Tori, Masayuki</creatorcontrib><creatorcontrib>Hashigaki, Satoshi</creatorcontrib><creatorcontrib>Kimura, Nobuyuki</creatorcontrib><creatorcontrib>Ohki, Emiko</creatorcontrib><creatorcontrib>Sawaki, Akira</creatorcontrib><creatorcontrib>Nishida, Toshirou</creatorcontrib><creatorcontrib>Yamao, Kenji</creatorcontrib><creatorcontrib>Imamura, Masayuki</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ito, Tetsuhide</au><au>Okusaka, Takuji</au><au>Tori, Masayuki</au><au>Hashigaki, Satoshi</au><au>Kimura, Nobuyuki</au><au>Ohki, Emiko</au><au>Sawaki, Akira</au><au>Nishida, Toshirou</au><au>Yamao, Kenji</au><au>Imamura, Masayuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Final phase II results for sunitinib (SU) in Japanese pts with well-differentiated pancreatic neuroendocrine tumor (NET)</atitle><jtitle>Annals of oncology</jtitle><date>2015-11</date><risdate>2015</risdate><volume>26</volume><spage>vii74</spage><epage>vii74</epage><pages>vii74-vii74</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1093/annonc/mdv466.02</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2015-11, Vol.26, p.vii74-vii74
issn 0923-7534
1569-8041
language eng
recordid cdi_crossref_primary_10_1093_annonc_mdv466_02
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Final phase II results for sunitinib (SU) in Japanese pts with well-differentiated pancreatic neuroendocrine tumor (NET)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A43%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Final%20phase%20II%20results%20for%20sunitinib%20(SU)%20in%20Japanese%20pts%20with%20well-differentiated%20pancreatic%20neuroendocrine%20tumor%20(NET)&rft.jtitle=Annals%20of%20oncology&rft.au=Ito,%20Tetsuhide&rft.date=2015-11&rft.volume=26&rft.spage=vii74&rft.epage=vii74&rft.pages=vii74-vii74&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdv466.02&rft_dat=%3Celsevier_cross%3ES0923753419468361%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0923753419468361&rfr_iscdi=true